Navigation Links
Data from Multiple Clinical Trials of OrbusNeich's Genous™ Bio-engineered R Stent™ Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented at TCT 2010
Date:9/25/2010

ces such as stents. The technology consists of an antibody surface coating that attracts EPCs circulating in the blood to the device to form an endothelial layer that provides protection against thrombosis and modulates restenosis.

OrbusNeich's Genous Bio-engineered R stent has been commercially available in over 60 countries since 2005. The Genous stent has been proven as a safe, effective alternative to drug-eluting stents and is supported by data from more than 5,000 patients in company-sponsored clinical studies. There is a growing body of evidence from multiple clinical studies that the Genous stent is effective for patients who are non-responsive to or cannot tolerate long-term dual antiplatelet therapy.

About OrbusNeich

OrbusNeich is a global company that designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. Current products are the world's first pro-healing stent, the Genous Bio-engineered R stent, as well as stents, balloons and guiding catheters marketed under the names of Blazer™, R stent, Scoreflex™, Sapphire™ and Sapphire NC. Development stage products include the Combo Bio-engineered Sirolimus Eluting Stent, or Combo Stent, which combines the Genous pro-healing technology for rapid endothelial coverage with an abluminal sirolimus drug elution for the control of neointimal proliferation. OrbusNeich is headquartered in Hong Kong and has operations in Shenzhen, China; Fort Lauderdale, Fla.; Hoevelaken, The Netherlands; and Tokyo, Japan. OrbusNeich, which has provided medical devices to physicians through its predecessor companies since 1979, supplies products today to interventional cardiologists in more than 60 countries. For more information, visit www.OrbusNeich.com.    


'/>"/>
SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
5. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
6. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
7. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
8. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
9. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 22, 2014  Mark Riccio, director of Cornell ... is using the online crowd-funding platform Kickstarter to ... to researchers and would-be superheros everywhere: "for FREE." ... YOU do if you had Superman,s X-ray vision?" ... explorers everywhere, from elementary through high school students, ...
(Date:8/22/2014)... 22, 2014  Cannabis Science, Inc. (OTC: CBIS), ... development and related consulting, is pleased to announce ... cannabis conference taking place at the Faculty of ... on October 22, 2014.  The multilingual conference brings ... researchers, health professionals, and patients, to discuss the ...
(Date:8/22/2014)... - SQI Diagnostics Inc. (TSX-V: SQD), a life ... and products for advanced microarray diagnostics, today announced ... Agreement to contract with a UK-based company to ... initial phase of this agreement, SQI will be ... one of the customer,s assays, operational on SQI,s ...
Breaking Medicine Technology:Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3
... March 16, 2011 Reportlinker.com announces that a ... catalogue: Global Freeze Drying Equipment ... This report analyzes the worldwide markets for ... following Product Segments: Laboratory Freeze Drying Equipment, and ...
... NEW YORK, March 16, 2011 Reportlinker.com announces ... in its catalogue: Global Analgesics ... This report analyzes the worldwide markets ... segments: Internal Analgesics, (Aspirin, Acetaminophen, Ibuprofen, and Others ...
Cached Medicine Technology:Global Freeze Drying Equipment Industry 2Global Freeze Drying Equipment Industry 3Global Freeze Drying Equipment Industry 4Global Freeze Drying Equipment Industry 5Global Freeze Drying Equipment Industry 6Global Freeze Drying Equipment Industry 7Global Freeze Drying Equipment Industry 8Global Freeze Drying Equipment Industry 9Global Freeze Drying Equipment Industry 10Global Freeze Drying Equipment Industry 11Global Freeze Drying Equipment Industry 12Global Freeze Drying Equipment Industry 13Global Freeze Drying Equipment Industry 14Global Freeze Drying Equipment Industry 15Global Analgesics Industry 2Global Analgesics Industry 3Global Analgesics Industry 4Global Analgesics Industry 5Global Analgesics Industry 6Global Analgesics Industry 7Global Analgesics Industry 8Global Analgesics Industry 9Global Analgesics Industry 10Global Analgesics Industry 11Global Analgesics Industry 12Global Analgesics Industry 13Global Analgesics Industry 14Global Analgesics Industry 15Global Analgesics Industry 16Global Analgesics Industry 17Global Analgesics Industry 18Global Analgesics Industry 19Global Analgesics Industry 20Global Analgesics Industry 21Global Analgesics Industry 22
(Date:8/22/2014)... DENVER For the first time an oncogenic somatic ... during transfection) protein has been identified in small cell ... mutation within SCLC cell lines produced increased intracellular signaling ... form of lung cancer representing 15% of all lung ... representing 85% of lung cancer, has been extensively examined ...
(Date:8/22/2014)... autoimmune disease that affects 1 to 2 percent ... with pain, disability and joint disfigurements, but also ... and marital functioning. While many pharmacological advances help ... common. In addition, some patients avoid newer medications ... Because of this, there is interest in psychosocial ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Restore ... Sen and Dr. Samantha Pearson to help people discover ... avoid corrective vision surgery by instead improving their eyesight ... an investigative review. , “There’s a reason why ... in revenue each year—it’s because people just assume that ...
(Date:8/22/2014)... New York (PRWEB) August 22, 2014 ... to be filed in U.S. courts on behalf ... due to their use of prescription low testosterone ... documents, a new claim was filed against Pfizer ... who allegedly suffered life-threatening heart issues due to ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Mueller Sports ... Plantar Fasciitis, an exciting new product that provides non-drug ... to stay active while you heal. The package includes ... truly a new technology – it is not kinesiology ... FasciaDerm® PFTape™ System for Plantar Fasciitis is ...
Breaking Medicine News(10 mins):Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis 2Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Mueller Introduces FasciaDerm® PFTape™ System for Plantar Fasciitis 2
... Inc.,(NYSE: ZMH ; SWX: ZMH), a leader ... participating in Merrill Lynch,s 19th Annual Global,Pharmaceutical, Biotechnology ... 5, 2008, at 8:00 a.m. Eastern Time., ... accessed via Zimmer,s,Investor Relations website at http://investor.zimmer.com ...
... several years of research into the gecko,s uncanny ability to ... have developed an adhesive that is the first to master ... feet. The material could prove useful for a range of ... tape or glue, the new material is crafted from millions ...
... giving radiation, study says , , TUESDAY, Jan. 29 ... gender and medical training, may influence whether a ... a U.S. study suggests. , Many breast ... conservation therapy, even though it,s been shown to ...
... disease , , TUESDAY, Jan. 29 (HealthDay News) -- A man,s ... of sex hormones circulating in his bloodstream, a new British ... of 18 studies -- representing 95 percent of all available ... and blood hormone levels, the study authors said. , "There ...
... Jan. 29 The following statement,was issued today by ... expected spin-off of Philip Morris International as a separate,company, ... greater,variety of deadly and addictive products around the world, ... implement proven measures to,reduce tobacco use and save lives. ...
... Jan. 29 Answering President,Bush,s State of the ... solutions to reform the nation,s retirement programs, the ... Center for Assisted,Living (AHCA/NCAL) and Alliance for Quality ... on this front by taking up long term,and ...
Cached Medicine News:Health News:The pitter patter of little feet... climbing straight up a wall 2Health News:Surgeons' Characteristics Influence Breast Cancer Care 2Health News:Sex Hormones Don't Seem to Affect Prostate Cancer Risk 2Health News:Sex Hormones Don't Seem to Affect Prostate Cancer Risk 3Health News:Philip Morris International Spin-off Should Spur Nations to Take Urgent Action to Reduce Tobacco Use 2Health News:Philip Morris International Spin-off Should Spur Nations to Take Urgent Action to Reduce Tobacco Use 3Health News:Answering Bush SOTU Retirement Reform Challenge, Long Term Care Profession Urges Congress to Enact Bold Reform of Long Term and Post Acute Care Delivery Systems 2
... Exp Expandable Tip System A lower ... allows you to perform multi-sample transfers between two ... of a knob, tip spacing can be quickly ... tubes) or 96 well plates. Ergonomic Design ...
... Expandable Tip System A lower cost alternative ... to perform multi-sample transfers between two different vessel ... knob, tip spacing can be quickly and easily ... 96 well plates. Ergonomic Design for Unparalleled ...
... The Equalizer With 384 Well Plate ... the revolutionary features of the original Equalizerexpandable and ... autoclavable components, and in-lab calibration capabilities. In addition, ... tips down to 4.5mm for loading and accessing ...
... 384 Well Plate Capability The Equalizer ... original Equalizerexpandable and equal tip spacing, choice of ... capabilities. In addition, this model allows you to ... loading and accessing many gels and for use ...
Medicine Products: